Question 1

Does Goldman Sachs own LYEL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs holds 86,779 shares of LYEL (Lyell Immunopharma), worth $1.2M.

Question 2

How many shares of LYEL does Goldman Sachs own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs holds 86,779 shares of LYEL (Lyell Immunopharma).

Question 3

What is Goldman Sachs' LYEL position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs' LYEL position is worth $1.2M.

Question 4

Is Goldman Sachs buying or selling LYEL?

Accepted Answer

In Q2 2026, Goldman Sachs reduced its LYEL position by 27,712 shares (-24.2%).

Question 5

When did Goldman Sachs first buy LYEL?

Accepted Answer

Goldman Sachs first reported LYEL in its Q4 2025 13F and has listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	86,779	-24.2%	$1.2M	0.0%	$14.05	0
2026-Q1	Increased	114,491	+18.4%	$2.3M	0.0%	$23.33	31
2025-Q4	New	96,675	-	$3M	0.0%	$31.59	36

LYEL3 quarters

LYEL
3 quarters